Comparative Pharmacology
Head-to-head clinical analysis: MONOFERRIC versus SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MONOFERRIC versus SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE.
MONOFERRIC vs SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Monomeric ferric iron replaces iron stores and is incorporated into hemoglobin, myoglobin, and enzymes, supporting erythropoiesis and oxygen transport.
Sodium ferric gluconate complex in sucrose provides elemental iron for hemoglobin synthesis and replenishes iron stores in iron-deficient states. The iron complex is taken up by the reticuloendothelial system, where iron is released and bound to transferrin for erythropoiesis.
100-200 mg elemental iron intravenously as a single dose, repeated weekly until iron stores are replete. Typical total dose is 1-2 g.
125 mg elemental iron (10 mL) intravenously over at least 10 minutes, given at sequential dialysis sessions to a cumulative total dose of 1000 mg elemental iron.
None Documented
None Documented
Terminal half-life: 10-14 hours for ferric carboxymaltose core; clinical effect persists for weeks due to iron utilization
Terminal elimination half-life is approximately 6 hours for the iron-sucrose complex; clinical context: indicates redistribution and utilization for erythropoiesis, with full hemoglobin correction over weeks.
Renal: <1% unchanged; Biliary/fecal: >99% as iron in RBC turnover and storage
Primarily excreted via feces (93%) as non-absorbed iron; renal elimination of absorbed iron is minimal (<1%).
Category C
Category C
Iron Supplement
Iron Supplement